Posted in | News | Medical Sensor

Sotera Wireless ViSi Mobile Patient Monitoring System Receives FDA Approval

Sotera Wireless declared that its full ViSi Mobile System has achieved 510(k) clearance from the U.S. Food and Drug Administration (FDA) and has started providing the system to nationwide hospitals.

The ViSi Mobile System employs WiFi (802.11) wireless technology for conveying the vital signs detected in patients. This system enables hospital clinicians to constantly remain connected to their patients.

During early 2012, Sotera reported 510(k) clearance for its G1 ViSi Mobile Monitor comprised of stand-alone device portion of the system. On a patient worn platform, this versatile device was able to seamlessly monitor the entire core vital signs, for the first time.

Various studies conducted over the years have demonstrated that patients in any hospital setting may be affected with preventable adverse events that may lead to extended hospitalization, injury or even death.

At present, continuous monitoring systems that allow detection of emerging problems are generally deployed in intensive care units (ICU) and other high-acuity areas of hospitals. In lower acuity areas where 60% to 70% of hospitalized patients are accommodated, collection of vital signs takes place using spot checks performed at an interval of 4-6 h.

The ViSi Mobile System is compactly configured for portability. It features non-invasive sensors that ensure convenience. It is ideal for effective deployment in ambulatory, and non-ICU clinical settings. The system can be used for precise capturing and wireless transmission of all core vital signs such as 3-lead or 5-lead ECG, SpO2, Blood Pressure, Heart Rate / Pulse Rate, Skin Temperature, and Respiration Rate.

Innovative sensing technologies such as Sotera's patented continuous non-invasive blood pressure (cNIBP) and patient posture/activity will be built within the upcoming versions of the ViSi Mobile System that are now in final stages of testing.

Source: http://www.soterawireless.com/

Disclaimer: The views expressed here are those of the author expressed in their private capacity and do not necessarily represent the views of AZoM.com Limited T/A AZoNetwork the owner and operator of this website. This disclaimer forms part of the Terms and conditions of use of this website.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Kaur, Kalwinder. (2019, February 24). Sotera Wireless ViSi Mobile Patient Monitoring System Receives FDA Approval. AZoSensors. Retrieved on April 29, 2024 from https://www.azosensors.com/news.aspx?newsID=4624.

  • MLA

    Kaur, Kalwinder. "Sotera Wireless ViSi Mobile Patient Monitoring System Receives FDA Approval". AZoSensors. 29 April 2024. <https://www.azosensors.com/news.aspx?newsID=4624>.

  • Chicago

    Kaur, Kalwinder. "Sotera Wireless ViSi Mobile Patient Monitoring System Receives FDA Approval". AZoSensors. https://www.azosensors.com/news.aspx?newsID=4624. (accessed April 29, 2024).

  • Harvard

    Kaur, Kalwinder. 2019. Sotera Wireless ViSi Mobile Patient Monitoring System Receives FDA Approval. AZoSensors, viewed 29 April 2024, https://www.azosensors.com/news.aspx?newsID=4624.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.